FI891986A0 - Farmaceutiska sammansaettningar foer behandling av psoriasis. - Google Patents

Farmaceutiska sammansaettningar foer behandling av psoriasis.

Info

Publication number
FI891986A0
FI891986A0 FI891986A FI891986A FI891986A0 FI 891986 A0 FI891986 A0 FI 891986A0 FI 891986 A FI891986 A FI 891986A FI 891986 A FI891986 A FI 891986A FI 891986 A0 FI891986 A0 FI 891986A0
Authority
FI
Finland
Prior art keywords
psoriasis
foer behandling
sammansaettningar
pharmaceutical
pharmaceutical sammansaettningar
Prior art date
Application number
FI891986A
Other languages
English (en)
Other versions
FI891986A (fi
Inventor
Izhak Blank
Original Assignee
Dexter Biotechnics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dexter Biotechnics filed Critical Dexter Biotechnics
Publication of FI891986A publication Critical patent/FI891986A/fi
Publication of FI891986A0 publication Critical patent/FI891986A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/09—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an acyclic unsaturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/49—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/52—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the nitrogen atom of at least one of the carboxamide groups further acylated
FI891986A 1987-09-04 1989-04-26 Farmaceutiska sammansaettningar foer behandling av psoriasis. FI891986A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL83775A IL83775A (en) 1987-09-04 1987-09-04 Amino acid esters and amides of fumaric acid and pharmaceutical compositions containing them for use in the treatment of psoriasis
PCT/US1988/002941 WO1989001930A1 (en) 1987-09-04 1988-09-01 Pharmaceutical compositions for the treatment of psoriasis

Publications (2)

Publication Number Publication Date
FI891986A FI891986A (fi) 1989-04-26
FI891986A0 true FI891986A0 (fi) 1989-04-26

Family

ID=11058151

Family Applications (1)

Application Number Title Priority Date Filing Date
FI891986A FI891986A0 (fi) 1987-09-04 1989-04-26 Farmaceutiska sammansaettningar foer behandling av psoriasis.

Country Status (14)

Country Link
EP (1) EP0328634B1 (fi)
JP (1) JPH0745451B2 (fi)
KR (1) KR890701545A (fi)
AT (1) ATE124681T1 (fi)
AU (1) AU618759B2 (fi)
CA (1) CA1340005C (fi)
DE (1) DE3854121T2 (fi)
DK (1) DK218189A (fi)
FI (1) FI891986A0 (fi)
IL (1) IL83775A (fi)
IN (1) IN167848B (fi)
NO (1) NO891703L (fi)
WO (1) WO1989001930A1 (fi)
ZA (1) ZA886097B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5290769A (en) * 1989-09-27 1994-03-01 Asta Pharma Aktiengesellschaft Use of hexadecylphosphocholine for the treatment of psoriasis
AU1271592A (en) * 1991-01-18 1992-08-27 Dexter Chemical Corporation Malic acid derivatives and compositions for the treatment of psoriasis
US5856418A (en) * 1996-04-16 1999-01-05 Nippon Shokubai Co., Ltd. Water-soluble monomer, water-soluble polymer and their production process and use
DE19853487A1 (de) 1998-11-19 2000-05-25 Fumapharm Ag Muri Verwendung von Dialkylfumaraten
PL392748A1 (pl) * 2001-01-12 2011-05-09 Fumapharm Ag Amidy kwasu fumarowego
DE10217314A1 (de) * 2002-04-18 2003-11-13 Fumapharm Ag Muri Carbocyclische und Oxacarboncyclische Fumarsäure-Oligomere
ES2297461T3 (es) 2003-09-09 2008-05-01 Fumapharm Ag Uso de derivados del acido fumarico para tratar la insuficiencia cardiaca y el asma.
FI121915B (fi) * 2004-02-06 2011-06-15 Neurofood Ab Oy Koostumus psoriasiksen hoitoon
ES2523796T1 (es) 2004-10-08 2014-12-01 Forward Pharma A/S Composición farmacéutica de liberación controlada que comprende éster de ácido fumárico
US20110112196A1 (en) 2007-02-08 2011-05-12 Matvey E Lukashev Nrf2 screening assays and related methods and compositions
US20100158829A1 (en) * 2008-12-24 2010-06-24 Conopco, Inc., D/B/A Unilever Method and Composition for Color Modulation
DK2564839T3 (en) 2009-01-09 2016-07-25 Forward Pharma As A pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix
WO2011085211A1 (en) * 2010-01-08 2011-07-14 Catabasis Pharmaceuticals, Inc. Fatty acid fumarate derivatives and their uses

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790032A (fr) * 1971-10-27 1973-02-01 Elf Union Procede de fonctionnement de bruleurs a emulsion a deux allures
JPS4852741A (fi) * 1971-11-04 1973-07-24
CA982530A (en) * 1972-05-23 1976-01-27 Roger Grenetier Device for storing and packaging materials
DE2703964A1 (de) * 1975-07-08 1978-08-03 Walter Dr Schweckendiek Pharmazeutische zubereitungen zur behandlung von psoriasis
JPS57102852A (en) * 1980-12-19 1982-06-26 Shionogi & Co Ltd Dicarboxylic acid diamide
US4362737A (en) * 1981-04-13 1982-12-07 Schaefer Rolf Transdermal carrier materials
DE3444915A1 (de) * 1984-12-08 1986-06-12 Hoechst Ag, 6230 Frankfurt N-maleyl-phenylalaninalkylester, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von n-fumarylphenylalaninalkylestern
JPS6248656A (ja) * 1985-08-28 1987-03-03 Showa Denko Kk Ｎ−フマリル−ｌ−フエニルアラニンメチルエステル及びその製法
US4730048A (en) * 1985-12-12 1988-03-08 Regents Of The University Of Minnesota Gut-selective opiates

Also Published As

Publication number Publication date
JPH02501072A (ja) 1990-04-12
DE3854121T2 (de) 1996-03-21
EP0328634A1 (en) 1989-08-23
KR890701545A (ko) 1989-12-20
NO891703D0 (no) 1989-04-25
WO1989001930A1 (en) 1989-03-09
CA1340005C (en) 1998-08-18
EP0328634B1 (en) 1995-07-05
IN167848B (fi) 1990-12-29
JPH0745451B2 (ja) 1995-05-17
DE3854121D1 (de) 1995-08-10
ZA886097B (en) 1989-06-28
AU2423788A (en) 1989-03-31
NO891703L (no) 1989-04-25
EP0328634A4 (en) 1991-08-21
DK218189A (da) 1989-07-03
IL83775A (en) 1991-12-15
IL83775A0 (en) 1988-02-29
FI891986A (fi) 1989-04-26
AU618759B2 (en) 1992-01-09
DK218189D0 (da) 1989-05-03
ATE124681T1 (de) 1995-07-15

Similar Documents

Publication Publication Date Title
DE122006000010I1 (de) Benzocyclobutyl- oder Indanyl-Alkyl-Amino-Alkyl substituierte 3- Benzazepin-2-ones, verwendbar in der Behandlung von kardiovaskularen Krankheiten
KR890701107A (ko) 알쯔하이머 병 치료용 화합물들
NO158741C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kvartaere dibenzotiepin-n-alkyl-norskopinetere.
DK158972C (da) Farmaceutiske formuleringer indeholdende benzothiophenderivater
FI891986A (fi) Farmaceutiska sammansaettningar foer behandling av psoriasis.
NZ217418A (en) Tricyclic heterocyclic compounds and pharmaceutical compositions
DK0417003T3 (da) Anvendelse af antiprogestomimetiske forbindelser til fremme af ovulation
ZA826453B (en) Tricyclic thiazolyloxamic acids and their derivatives,their preparation,and therapeutic agents containing these compounds
NO913117D0 (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
DE2966809D1 (en) 3,4-diaza-bicyclo(4.1.0)hepten-2-ones-5, process for their preparation and therapeutical compositions containing them
NO880405D0 (no) Fremgangsmaate til fremstilling av 3-fenyl-7h-tiazolo-/3,2-b//1,2,4/-tiazine-7-oner.
DE3879709T2 (de) Platin-arzneimittel.
NO884635D0 (no) Fremgangsmaate for behandling av most.
NO170493C (no) Fremgangsmaate for hydrogenerende behandling av klorholdige forbindelser
NO905643D0 (no) Fremgangsmaate for behandling av manganslam.
NO920694D0 (no) Fremgangsmaate for etterbehandling av tremasse

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: DEXTER CHEMICAL CORPORATION